The Role of Intracranial Electroencephalography (IEEG) in the Localization of Epileptogenic Zones (EZ) and Its Relationship With Prognosis
Status
Conditions
Details and patient eligibility
About
The mechanism of epilepsy pathogenesis is complex and not fully defined, and about 20-30% of patients with seizures that cannot be completely controlled by drugs become drug-resistant epilepsy. For focal drug-resistant epilepsy, surgical removal of the epileptogenic zone can control seizures, but the overall seizure-free rate in the long term after surgery is 60-70%, and the results are still not satisfactory. Accurate assessment of the location and extent of the epileptogenic zone and its adequate excision are prerequisites for the success or failure of surgery. Intracranial EEG (iEEG) has been shown to be the most accurate method for determining the location and boundaries of the epileptogenic zone. It can selectively record the local cortical electrical activity through intracranial electrodes and achieve high temporal resolution for long-range recording, reliably reflecting the continuous dynamic changes of EEG during interictal and ictal periods. The in-depth analysis of iEEG can improve the efficacy of epilepsy surgery and provide important information to reveal the pathogenesis of epilepsy.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Complete clinical history;
- IEEG monitoring at least one habitual seizure；
- Follow up for at least 1 year；
- Signed informed consent.
Exclusion criteria
- Habitual seizures were not found in iEEG monitoring;
- No operation was performed;
- Lost to follow-up for various reasons within 1 year after surgery.
Trial design
120 participants in 2 patient groups
Trial contacts and locations
Loading...
Central trial contact
Lingli Hu, Master
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal